Theodore Cohen, contributor to SeekingAlpha.com interviewed Dr. Deepak A. Kapoor about Dendreon’s Provenge, Johnson and Johnson’s Zytiga, and Medivation’s Xtandi. “In our practice we manage patients based on prospective clinical guidelines based best practice models developed from evidence-based medicine and national consensus clinical protocols” says Dr. Kapoor.
To read the complete interview, please click here.
